| Literature DB >> 30568982 |
María Jesús Rodríguez-Revuelta1, Lorena López-Cerero2, Lara Serrano2, Salud Luna-Lagares1, Alvaro Pascual2, Jesús Rodríguez-Baño2.
Abstract
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and factors associated with it were studied in 20 newborns in Seville, Spain. Median duration of colonization was 7.5 months; factors associated with prolonged colonization were delivery by caesarean section, colonization of the mother, and phylogroup B2 Eschericha coli isolate.Entities:
Keywords: Escherichia coli; colonization; extended-spectrum β-lactamases; newborns; risk factors
Year: 2018 PMID: 30568982 PMCID: PMC6293479 DOI: 10.1093/ofid/ofy312
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Figure 1.Probability of clearance of colonization in children colonized with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Univariate and Multivariate Analysis of Variables Associated With Clearance of ESBL-E Colonization in Childrena
| Variable | Category | Colonization | Crude HR |
| Adjusted HR |
|
|---|---|---|---|---|---|---|
|
| ||||||
| Gender | Male | 9/10 (90) | 2.01 (0.75–5.36) | .1 | ||
| Delivery by caesarean section | Yes | 2/4 (50) | 0.43 (0.09–1.88) | .2 | 0.18 (0.03–0.91) | .03 |
| Travel outside Spain | Yes | 2/2 (100) | 0.69 (0.15–3.06) | .6 | ||
| New household member | Yes | 1/1 (100) | 0.53 (0.06–4.17) | .5 | ||
| Pets | Yes | 6/7 (85.7) | 0.89 (0.32–2.44) | .8 | ||
| Breastfeeding | Yes | 11/11 (100) | 1.17 (0.43–3.22) | .7 | ||
| Sterilization of feeding bottles | Yes | 11/13 (84.6) | 0.50 (0.17–1.48) | .2 | ||
| Fed with homemade puree | Yes | 14/17 (82.4) | 0.73 (0.20–2.62) | .6 | ||
| Nursery attendee | Yes | 2/4 (50) | 0.67 (0.15–2.99) | .6 | ||
| Any chronic disease | Yes | 1/2 (50) | 0.67 (0.08–5.17) | .7 | ||
| Any pediatric visit for acute illnessb | Yes | 5/7 (71.4) | 0.64 (0.22–1.84) | .4 | ||
| Hospitalizationb | Yes | 1/2 (50) | 0.32 (0.04–2.44) | .2 | ||
| Antibiotic useb | Yes | 3/5 (60) | 0.39 (0.11–1.38) | .1 | ||
| Colonization with ESBL-E at birth | Yes | 11/11 (100) | 1.15 (0.42–3.17) | .7 | ||
| Time of acquisition of ESBL-E | ≤3 months >3 months | 12/13 (92.3) | 0.46 (0.14–1.50) | .2 | ||
| Mother colonized with the same ESBL-E clone | Yes | 9/10 (90) | 1.4 (0.53–3.69) | .5 | ||
|
| ||||||
| Caregiver of a disabled person | Yes | 2/3 (66.7) | 0.72 (0.16–3.22) | .6 | ||
| Any chronic disease | Yes | 2/3 (66.7) | 0.47 (0.10–2.08) | .3 | ||
| Any doctor’s visit for acute illness | Yes | 1/1 (100) | 0.21 (0.02–1.69) | .1 | ||
| Hospitalization | Yes | 0/0 (0) | -- | -- | ||
| Antibiotic use | Yes | 1/2 (50) | 0.21 (0.02–1.69) | .1 | ||
| Mother colonized | Yes | 11/13 (84.6) | 0.62 (0.22–1.71) | .3 | 0.31 (0.10–1.01) | .05 |
|
| ||||||
| CTX-M producer | Yes | 12/15 (80) | 1.23 (0.42–3.55) | .6 | 5.15 (1.29–20.55) | .02 |
| SHV-12 producer | Yes | 7/8 (87.5) | 0.70 (0.25–1.91) | .4 | ||
| Phylogroup A | Yes | 10/11 (90.9) | 1.06 (0.40–2.79) | .9 | ||
| Phylogroup B1 | Yes | 2/3 (66.7) | 1.18 (0.26–5.31) | .8 | ||
| Phylogroup B2 | Yes | 4/6 (66.7) | 0.51 (0.16–1.58) | .2 | 0.20 (0.05–0.81) | .02 |
| Phylogroup D | Yes | 6/7 (85.7) | 1.01 (0.37–2.77) | .9 |
Abbreviations: CI, confidence interval; ESBL-E, extended-spectrum β-lactamase-producing Enterobacteriaceae; HR, hazard ratio.
aExposures are considered for the whole period from detection of colonization to clearance, or censoring, except where specified.
bNone of these were related to infection due to ESBL producers.